<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Combined central <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:mp ids='MP_0006134'>artery occlusion</z:mp> and central <z:chebi fb="46" ids="15035">retinal</z:chebi> venous occlusion have been rarely reported in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome </plain></SENT>
<SENT sid="1" pm="."><plain>The impact of this severe <z:e sem="disease" ids="C0948441" disease_type="Disease or Syndrome" abbrv="VOD">vaso-occlusive disease</z:e> on vision is usually devastating and permanent in spite of vigorous treatment </plain></SENT>
<SENT sid="2" pm="."><plain>We report herein a 35-year-old female patient displaying a transient and reversible process </plain></SENT>
<SENT sid="3" pm="."><plain>Her best-corrected visual acuity improved from 6/60 to 6/8.6 1 day later, before the initiation of systemic <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> and <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> treatment </plain></SENT>
<SENT sid="4" pm="."><plain>The retina regained a <z:mpath ids='MPATH_458'>normal</z:mpath> appearance with her vision recovering to 6/6 2 weeks after the episode of temporary <z:e sem="disease" ids="C0456909" disease_type="Disease or Syndrome" abbrv="">vision loss</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Her rapid recovery suggests that continued anti-coagulation therapy and close follow-up to prevent severe complications and <z:hpo ids='HP_0004419'>recurrent thrombosis</z:hpo> is warranted </plain></SENT>
</text></document>